Dark Horse Conference Participation, 2022
Check back regularly for updates; COVID-19 remains a moving target!
Phacilitate’s Advanced Therapies Week, 2022
January 25-28, 2022
DHC attendees: Anthony Davies, Katy Spink, Rob Allen, Don Fink, Scott Cross, Sanjin Zvonić, Nate Manley, Sara Mills, Ben Nelson, Christina Fuentes, Uzma Shoukat-Mumtaz, Oliver Ball, Rachel Choate
CEO Anthony Davies will be chairing the Superplenary session, complete with three fireside chats, from the Patient Perspective, the Pharma Perspective, and the Investor Perspective.
Anthony will also be chairing Overcoming the Commercial Roadblocks for Cell and Gene Therapy Success
January 25, 2022
DHC attendees: Katy Spink
COO Katy Spink will be a January 25th panelist in the ISCT Commercialization Signature Series, an ISCT exclusive event that will be co-located with Advanced Therapies Week at the Miami Convention Center.
Meeting on the Med (ARM)
April 20-22, 2022
May 4-7, 2022
May 16-19, 2022
May 24-25, 2022
ExCeL, London, UK
Meeting on the Mesa (ARM)
Oct 11-13, 2022
San Diego, CA
Cell & Gene Therapy Mfg & Commercialization Europe
December 5-8, 2022
Beurs van Berlage,